Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Rheumatology Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Rheumatology Therapeuticsmarket, defines the market attractiveness level of Rheumatology Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Rheumatology Therapeutics industry, describes the types of Rheumatology Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Rheumatology Therapeutics market and the development prospects and opportunities of Rheumatology Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Rheumatology Therapeutics market in Chapter 13.
By Player:
Novartis
Amgen
Merck & Co
Janssen Biotech
Pfizer
Takeda
Sanofi
Bristol-Myers Squibb
Genentech
AbbVie
By Type:
Rheumatoid Arthritis
Osteoarthritis
Lupus
Gout
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Rheumatology Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Rheumatology Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Rheumatology Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Rheumatology Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Rheumatology Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Rheumatology Therapeutics Consumption (2017-2022)
-
7.2 United States Rheumatology Therapeutics Consumption (2017-2022)
-
7.3 Europe Rheumatology Therapeutics Consumption (2017-2022)
-
7.4 China Rheumatology Therapeutics Consumption (2017-2022)
-
7.5 Japan Rheumatology Therapeutics Consumption (2017-2022)
-
7.6 India Rheumatology Therapeutics Consumption (2017-2022)
-
7.7 South Korea Rheumatology Therapeutics Consumption (2017-2022)
8 Region and Country-wise Rheumatology Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Rheumatology Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Rheumatology Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Rheumatology Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Rheumatology Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Rheumatology Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Rheumatology Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Rheumatology Therapeutics Consumption Forecast (2022-2028)
9 Global Rheumatology Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Rheumatology Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Osteoarthritis Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Lupus Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Gout Consumption and Growth Rate (2017-2022)
-
9.2 Global Rheumatology Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Rheumatology Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Rheumatology Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Lupus Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Gout Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Rheumatology Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Rheumatology Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Rheumatology Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Rheumatology Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Rheumatology Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Rheumatology Therapeutics Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Rheumatology Therapeutics Product and Service
-
14.2 Amgen
-
14.2.1 Amgen Company Details
-
14.2.2 Amgen Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Amgen Rheumatology Therapeutics Product and Service
-
14.3 Merck & Co
-
14.3.1 Merck & Co Company Details
-
14.3.2 Merck & Co Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck & Co Rheumatology Therapeutics Product and Service
-
14.4 Janssen Biotech
-
14.4.1 Janssen Biotech Company Details
-
14.4.2 Janssen Biotech Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Janssen Biotech Rheumatology Therapeutics Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Rheumatology Therapeutics Product and Service
-
14.6 Takeda
-
14.6.1 Takeda Company Details
-
14.6.2 Takeda Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Takeda Rheumatology Therapeutics Product and Service
-
14.7 Sanofi
-
14.7.1 Sanofi Company Details
-
14.7.2 Sanofi Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi Rheumatology Therapeutics Product and Service
-
14.8 Bristol-Myers Squibb
-
14.8.1 Bristol-Myers Squibb Company Details
-
14.8.2 Bristol-Myers Squibb Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bristol-Myers Squibb Rheumatology Therapeutics Product and Service
-
14.9 Genentech
-
14.9.1 Genentech Company Details
-
14.9.2 Genentech Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Genentech Rheumatology Therapeutics Product and Service
-
14.10 AbbVie
-
14.10.1 AbbVie Company Details
-
14.10.2 AbbVie Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 AbbVie Rheumatology Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Rheumatology Therapeutics
-
Figure Rheumatology Therapeutics Picture
-
Table Global Rheumatology Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rheumatology Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rheumatology Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Rheumatology Therapeutics Consumption by Country (2017-2022)
-
Figure United States Rheumatology Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Rheumatology Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Rheumatology Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Rheumatology Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Rheumatology Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Rheumatology Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatology Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Rheumatology Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Rheumatology Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Rheumatology Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Rheumatology Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Rheumatology Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Rheumatology Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Osteoarthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Lupus Consumption and Growth Rate (2017-2022)
-
Figure Global Gout Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lupus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gout Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Rheumatology Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Rheumatology Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Rheumatology Therapeutics Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Rheumatology Therapeutics Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Rheumatology Therapeutics Product and Service
-
Table Janssen Biotech (Foundation Year, Company Profile and etc.)
-
Table Janssen Biotech Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech Rheumatology Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Rheumatology Therapeutics Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Rheumatology Therapeutics Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Rheumatology Therapeutics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Rheumatology Therapeutics Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Rheumatology Therapeutics Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Rheumatology Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Rheumatology Therapeutics Product and Service
-
